Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low Axillary Nodal Metastasis Rates in Selected HER2-Positive and Triple-Negative Breast Cancer Patients: Toward De-escalation of Sentinel Lymph Node Biopsy

NCT07211451 is registered in ClinicalTrials.gov with Gangnam Severance Hospital as lead sponsor.

NCT NCT07211451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07211451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low Axillary Nodal Metastasis Rates in Selected HER2-Positive and Triple-Negative Breast Cancer Patients: Toward De-escalation of Sentinel Lymph Node Biopsy
Lead sponsor
Gangnam Severance Hospital
Phase
Observational
Overall status
Completed
Start date
June 1, 2025
Completion date
September 30, 2025
Enrollment
1,571 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer